Teladoc Health (NYSE:TDOC) Trading 5.1% Higher

Teladoc Health Inc (NYSE:TDOC)’s stock price was up 5.1% on Wednesday . The stock traded as high as $68.18 and last traded at $68.08, approximately 1,341,586 shares were traded during trading. A decline of 0% from the average daily volume of 1,347,052 shares. The stock had previously closed at $64.78.

A number of research analysts recently commented on the stock. Oppenheimer set a $83.00 target price on shares of Teladoc Health and gave the company a “buy” rating in a research report on Friday, September 6th. Svb Leerink reiterated an “outperform” rating on shares of Teladoc Health in a research note on Thursday, August 1st. ValuEngine raised shares of Teladoc Health from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 27th. SunTrust Banks upped their price objective on shares of Teladoc Health to $80.00 and gave the company a “positive” rating in a research note on Tuesday, August 6th. Finally, Craig Hallum raised their price objective on Teladoc Health from $70.00 to $80.00 and gave the stock a “buy” rating in a report on Thursday, August 1st. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $82.94.

The stock has a market cap of $4.66 billion, a price-to-earnings ratio of -47.28 and a beta of 1.35. The stock’s 50 day moving average is $63.02 and its two-hundred day moving average is $61.31. The company has a current ratio of 7.56, a quick ratio of 7.56 and a debt-to-equity ratio of 0.43.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, July 31st. The health services provider reported ($0.41) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.40) by ($0.01). The business had revenue of $130.30 million for the quarter, compared to analysts’ expectations of $129.54 million. Teladoc Health had a negative return on equity of 10.64% and a negative net margin of 21.85%. The company’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same period in the previous year, the business posted ($0.40) earnings per share. On average, sell-side analysts predict that Teladoc Health Inc will post -1.56 EPS for the current year.

In other news, insider Lewis Levy sold 675 shares of the business’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $60.00, for a total value of $40,500.00. Following the transaction, the insider now owns 4,805 shares of the company’s stock, valued at $288,300. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, President Peter A. Mcclennen sold 8,359 shares of the company’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $60.02, for a total value of $501,707.18. Following the sale, the president now owns 11,400 shares of the company’s stock, valued at approximately $684,228. The disclosure for this sale can be found here. Insiders have sold 132,562 shares of company stock valued at $8,855,846 in the last quarter. Insiders own 3.14% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Nuveen Asset Management LLC grew its position in Teladoc Health by 2,939.6% in the 2nd quarter. Nuveen Asset Management LLC now owns 608,824 shares of the health services provider’s stock valued at $40,432,000 after buying an additional 588,794 shares during the last quarter. Waddell & Reed Financial Inc. boosted its holdings in shares of Teladoc Health by 32.5% in the second quarter. Waddell & Reed Financial Inc. now owns 2,335,837 shares of the health services provider’s stock valued at $155,123,000 after acquiring an additional 572,388 shares in the last quarter. Nikko Asset Management Americas Inc. boosted its holdings in shares of Teladoc Health by 324.5% in the second quarter. Nikko Asset Management Americas Inc. now owns 721,771 shares of the health services provider’s stock valued at $47,933,000 after acquiring an additional 551,755 shares in the last quarter. Jennison Associates LLC boosted its holdings in shares of Teladoc Health by 60.6% in the second quarter. Jennison Associates LLC now owns 1,172,135 shares of the health services provider’s stock valued at $77,841,000 after acquiring an additional 442,140 shares in the last quarter. Finally, Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of Teladoc Health by 191.3% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 485,058 shares of the health services provider’s stock worth $32,213,000 after acquiring an additional 318,538 shares during the period.

About Teladoc Health (NYSE:TDOC)

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Further Reading: What are gap-up stocks?

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.